Marie-rose S. Crombag

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2026

Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital.

Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital.

Journal: European journal of hospital pharmacy : science and practice

Published: September 03, 2025

Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach.

Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach.

Journal: Applied health economics and health policy

Published: November 28, 2024

A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.

A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups.

Journal: Clinical pharmacokinetics

Published: October 23, 2024

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response.

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response.

Journal: iScience

Published: June 25, 2023

Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction.

Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction.

Journal: Inflammatory bowel diseases

Published: February 04, 2022

Is age just a number? A population pharmacokinetic study of gemcitabine.

Is age just a number? A population pharmacokinetic study of gemcitabine.

Journal: Cancer chemotherapy and pharmacology

Published: December 27, 2021

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients.

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 10, 2020

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: June 25, 2020

Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study.

Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study.

Journal: Pharmaceutical research

Published: May 10, 2019

Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?

Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?

Journal: Pharmaceutical research

Published: April 06, 2019

Treatment of older patients with immune checkpoint inhibitors in routine clinical care as compared to inclusion in pivotal registration trials.

Treatment of older patients with immune checkpoint inhibitors in routine clinical care as compared to inclusion in pivotal registration trials.

Journal: Journal of geriatric oncology

Published: April 05, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026